Onconova adopts BioClinica Express
BioClinica Express EDC offers standard RECIST (Response Evaluation Criteria In Solid Tumors) eCRFs that automatically calculate overall tumor response based on the data entered. A dynamic lesion form
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.
Under the terms of the deal, Cognizant will offer centralized statistical programming, statistical analysis, medical writing, and document publishing services, covering clinical data reporting, from case report forms
Researchers from Cuba intend to step-up the national production of antineoplastic and complementary drugs, besides making biotechnological products, cubanews.ain.cu reported citing cubadebate.cu. It is estimated that following the